Ohio Public Employees Retirement System (OPERS)
RVNC

Ohio Public Employees Retirement System (OPERS)’s Revance Therapeutics, Inc. RVNC Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-13,800
Closed -$179K – 1965
2019
Q3 		$179K Buy
+13,800
New +$169K ﹤0.01% 1518

Other funds holding RVNC

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
NCM
NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s RVNC Position: Q4 2019 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Revance Therapeutics, Inc. (RVNC) in Q4 2019, closing a stake of 13,800 shares — an estimated $179K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in RVNC in Q3 2019 and held it in 1 quarter. The position peaked at $179K in Q3 2019. 134 funds tracked by Wall St. Rank hold RVNC as of Q4 2019.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Revance Therapeutics, Inc. position as of Q4 2019 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 13,800 Revance Therapeutics, Inc. shares in Q4 2019, an estimated $179K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Revance Therapeutics, Inc. in Q3 2019 and held it in 1 quarter.
  • Ohio Public Employees Retirement System (OPERS)'s Revance Therapeutics, Inc. position peaked at $179K in Q3 2019.
  • 134 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q4 2019.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q4 2019, filed 14 Feb 2020.